Loading…

Perception Measurement in Clinical Trials of Schizophrenia: Promising Paradigms From CNTRICS

The third meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) focused on selecting promising measures for each of the cognitive constructs selected in the first CNTRICS meeting. In the domain of perception, the 2 constructs of interest were gain c...

Full description

Saved in:
Bibliographic Details
Published in:Schizophrenia bulletin 2009-01, Vol.35 (1), p.163-181
Main Authors: Green, Michael F., Butler, Pamela D., Chen, Yue, Geyer, Mark A., Silverstein, Steven, Wynn, Jonathan K., Yoon, Jong H., Zemon, Vance
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c541t-893ca1e1e684e40ce78e0b6820a73108c087ee34e576178910a8cfb4349fb0203
cites cdi_FETCH-LOGICAL-c541t-893ca1e1e684e40ce78e0b6820a73108c087ee34e576178910a8cfb4349fb0203
container_end_page 181
container_issue 1
container_start_page 163
container_title Schizophrenia bulletin
container_volume 35
creator Green, Michael F.
Butler, Pamela D.
Chen, Yue
Geyer, Mark A.
Silverstein, Steven
Wynn, Jonathan K.
Yoon, Jong H.
Zemon, Vance
description The third meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) focused on selecting promising measures for each of the cognitive constructs selected in the first CNTRICS meeting. In the domain of perception, the 2 constructs of interest were gain control and visual integration. CNTRICS received 5 task nominations for gain control and three task nominations for visual integration. The breakout group for perception evaluated the degree to which each of these tasks met prespecified criteria. For gain control, the breakout group for perception believed that 2 of the tasks (prepulse inhibition of startle and mismatch negativity) were already mature and in the process of being incorporated into multisite clinical trials. However, the breakout group recommended that steady-state visual-evoked potentials be combined with contrast sensitivity to magnocellular vs parvocellular biased stimuli and that this combined task and the contrast-contrast effect task be recommended for translation for use in clinical trial contexts in schizophrenia research. For visual integration, the breakout group recommended the Contour Integration and Coherent Motion tasks for translation for use in clinical trials. This manuscript describes the ways in which each of these tasks met the criteria used by the breakout group to evaluate and recommend tasks for further development.
doi_str_mv 10.1093/schbul/sbn156
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2635893</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/schbul/sbn156</oup_id><sourcerecordid>1614441691</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-893ca1e1e684e40ce78e0b6820a73108c087ee34e576178910a8cfb4349fb0203</originalsourceid><addsrcrecordid>eNqFkc2L1DAYh4Mo7jh69CpBULzUzVeTdA-CFFcXVh3c8SaENPt2Jkub1GQq6F9vpMP6cfEUSJ783vfHg9BjSl5S0vDT7PbdPJzmLtBa3kErqkRdUUXoXbQitZaVklScoAc53xBCRSPZfXRCG8I4ZXyFvmwgOZgOPgb8HmyeE4wQDtgH3A4-eGcHvE3eDhnHHl-5vf8Rp32C4O0Z3qQ4-uzDDm9sstd-N2Z8Xu5w-2H76aK9eoju9eUnPDqea_T5_M22fVddfnx70b6-rFwt6KHSDXeWAgWpBQjiQGkgndSMWMUp0Y5oBcAF1KWL0g0lVru-E1w0fUcY4Wv0asmd5m6Ea1cKJDuYKfnRpu8mWm_-fgl-b3bxm2GS12V6CXh-DEjx6wz5YEovB8NgA8Q5GymVUI2kBXz6D3gT5xRKOcMYr7nQxckaVQvkUsw5QX-7CSXmlzSzSDOLtMI_-XP93_TRUgGeHQGbi5A-2eB8vuUYLRAVqnAvFi7O039m_gTaW695</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223534809</pqid></control><display><type>article</type><title>Perception Measurement in Clinical Trials of Schizophrenia: Promising Paradigms From CNTRICS</title><source>Oxford Journals Online</source><source>PubMed Central</source><creator>Green, Michael F. ; Butler, Pamela D. ; Chen, Yue ; Geyer, Mark A. ; Silverstein, Steven ; Wynn, Jonathan K. ; Yoon, Jong H. ; Zemon, Vance</creator><creatorcontrib>Green, Michael F. ; Butler, Pamela D. ; Chen, Yue ; Geyer, Mark A. ; Silverstein, Steven ; Wynn, Jonathan K. ; Yoon, Jong H. ; Zemon, Vance</creatorcontrib><description>The third meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) focused on selecting promising measures for each of the cognitive constructs selected in the first CNTRICS meeting. In the domain of perception, the 2 constructs of interest were gain control and visual integration. CNTRICS received 5 task nominations for gain control and three task nominations for visual integration. The breakout group for perception evaluated the degree to which each of these tasks met prespecified criteria. For gain control, the breakout group for perception believed that 2 of the tasks (prepulse inhibition of startle and mismatch negativity) were already mature and in the process of being incorporated into multisite clinical trials. However, the breakout group recommended that steady-state visual-evoked potentials be combined with contrast sensitivity to magnocellular vs parvocellular biased stimuli and that this combined task and the contrast-contrast effect task be recommended for translation for use in clinical trial contexts in schizophrenia research. For visual integration, the breakout group recommended the Contour Integration and Coherent Motion tasks for translation for use in clinical trials. This manuscript describes the ways in which each of these tasks met the criteria used by the breakout group to evaluate and recommend tasks for further development.</description><identifier>ISSN: 0586-7614</identifier><identifier>EISSN: 1745-1701</identifier><identifier>DOI: 10.1093/schbul/sbn156</identifier><identifier>PMID: 19023123</identifier><identifier>CODEN: SCZBB3</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult and adolescent clinical studies ; Animals ; Biological and medical sciences ; Clinical Trials as Topic ; Evoked Potentials, Visual - physiology ; Humans ; Magnetic Resonance Imaging ; Medical sciences ; Perceptual Disorders - diagnosis ; Perceptual Disorders - etiology ; Psychology. Psychoanalysis. Psychiatry ; Psychometrics ; Psychopathology. Psychiatry ; Psychoses ; Reflex, Startle ; Schizophrenia ; Schizophrenia - complications ; Schizophrenia - physiopathology ; Theme: Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: Proceedings of the 3rd CNTRICS meeting Guest Editor: Deanna Barch ; Visual Perception</subject><ispartof>Schizophrenia bulletin, 2009-01, Vol.35 (1), p.163-181</ispartof><rights>The Author 2008. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org. 2009</rights><rights>2009 INIST-CNRS</rights><rights>The Author 2008. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-893ca1e1e684e40ce78e0b6820a73108c087ee34e576178910a8cfb4349fb0203</citedby><cites>FETCH-LOGICAL-c541t-893ca1e1e684e40ce78e0b6820a73108c087ee34e576178910a8cfb4349fb0203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635893/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635893/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,309,310,314,727,780,784,789,790,885,23929,23930,25139,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21123147$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19023123$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Green, Michael F.</creatorcontrib><creatorcontrib>Butler, Pamela D.</creatorcontrib><creatorcontrib>Chen, Yue</creatorcontrib><creatorcontrib>Geyer, Mark A.</creatorcontrib><creatorcontrib>Silverstein, Steven</creatorcontrib><creatorcontrib>Wynn, Jonathan K.</creatorcontrib><creatorcontrib>Yoon, Jong H.</creatorcontrib><creatorcontrib>Zemon, Vance</creatorcontrib><title>Perception Measurement in Clinical Trials of Schizophrenia: Promising Paradigms From CNTRICS</title><title>Schizophrenia bulletin</title><addtitle>Schizophr Bull</addtitle><description>The third meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) focused on selecting promising measures for each of the cognitive constructs selected in the first CNTRICS meeting. In the domain of perception, the 2 constructs of interest were gain control and visual integration. CNTRICS received 5 task nominations for gain control and three task nominations for visual integration. The breakout group for perception evaluated the degree to which each of these tasks met prespecified criteria. For gain control, the breakout group for perception believed that 2 of the tasks (prepulse inhibition of startle and mismatch negativity) were already mature and in the process of being incorporated into multisite clinical trials. However, the breakout group recommended that steady-state visual-evoked potentials be combined with contrast sensitivity to magnocellular vs parvocellular biased stimuli and that this combined task and the contrast-contrast effect task be recommended for translation for use in clinical trial contexts in schizophrenia research. For visual integration, the breakout group recommended the Contour Integration and Coherent Motion tasks for translation for use in clinical trials. This manuscript describes the ways in which each of these tasks met the criteria used by the breakout group to evaluate and recommend tasks for further development.</description><subject>Adult and adolescent clinical studies</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Clinical Trials as Topic</subject><subject>Evoked Potentials, Visual - physiology</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Medical sciences</subject><subject>Perceptual Disorders - diagnosis</subject><subject>Perceptual Disorders - etiology</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychometrics</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Reflex, Startle</subject><subject>Schizophrenia</subject><subject>Schizophrenia - complications</subject><subject>Schizophrenia - physiopathology</subject><subject>Theme: Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: Proceedings of the 3rd CNTRICS meeting Guest Editor: Deanna Barch</subject><subject>Visual Perception</subject><issn>0586-7614</issn><issn>1745-1701</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFkc2L1DAYh4Mo7jh69CpBULzUzVeTdA-CFFcXVh3c8SaENPt2Jkub1GQq6F9vpMP6cfEUSJ783vfHg9BjSl5S0vDT7PbdPJzmLtBa3kErqkRdUUXoXbQitZaVklScoAc53xBCRSPZfXRCG8I4ZXyFvmwgOZgOPgb8HmyeE4wQDtgH3A4-eGcHvE3eDhnHHl-5vf8Rp32C4O0Z3qQ4-uzDDm9sstd-N2Z8Xu5w-2H76aK9eoju9eUnPDqea_T5_M22fVddfnx70b6-rFwt6KHSDXeWAgWpBQjiQGkgndSMWMUp0Y5oBcAF1KWL0g0lVru-E1w0fUcY4Wv0asmd5m6Ea1cKJDuYKfnRpu8mWm_-fgl-b3bxm2GS12V6CXh-DEjx6wz5YEovB8NgA8Q5GymVUI2kBXz6D3gT5xRKOcMYr7nQxckaVQvkUsw5QX-7CSXmlzSzSDOLtMI_-XP93_TRUgGeHQGbi5A-2eB8vuUYLRAVqnAvFi7O039m_gTaW695</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>Green, Michael F.</creator><creator>Butler, Pamela D.</creator><creator>Chen, Yue</creator><creator>Geyer, Mark A.</creator><creator>Silverstein, Steven</creator><creator>Wynn, Jonathan K.</creator><creator>Yoon, Jong H.</creator><creator>Zemon, Vance</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20090101</creationdate><title>Perception Measurement in Clinical Trials of Schizophrenia: Promising Paradigms From CNTRICS</title><author>Green, Michael F. ; Butler, Pamela D. ; Chen, Yue ; Geyer, Mark A. ; Silverstein, Steven ; Wynn, Jonathan K. ; Yoon, Jong H. ; Zemon, Vance</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-893ca1e1e684e40ce78e0b6820a73108c087ee34e576178910a8cfb4349fb0203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Clinical Trials as Topic</topic><topic>Evoked Potentials, Visual - physiology</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Medical sciences</topic><topic>Perceptual Disorders - diagnosis</topic><topic>Perceptual Disorders - etiology</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychometrics</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Reflex, Startle</topic><topic>Schizophrenia</topic><topic>Schizophrenia - complications</topic><topic>Schizophrenia - physiopathology</topic><topic>Theme: Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: Proceedings of the 3rd CNTRICS meeting Guest Editor: Deanna Barch</topic><topic>Visual Perception</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Green, Michael F.</creatorcontrib><creatorcontrib>Butler, Pamela D.</creatorcontrib><creatorcontrib>Chen, Yue</creatorcontrib><creatorcontrib>Geyer, Mark A.</creatorcontrib><creatorcontrib>Silverstein, Steven</creatorcontrib><creatorcontrib>Wynn, Jonathan K.</creatorcontrib><creatorcontrib>Yoon, Jong H.</creatorcontrib><creatorcontrib>Zemon, Vance</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Schizophrenia bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Green, Michael F.</au><au>Butler, Pamela D.</au><au>Chen, Yue</au><au>Geyer, Mark A.</au><au>Silverstein, Steven</au><au>Wynn, Jonathan K.</au><au>Yoon, Jong H.</au><au>Zemon, Vance</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Perception Measurement in Clinical Trials of Schizophrenia: Promising Paradigms From CNTRICS</atitle><jtitle>Schizophrenia bulletin</jtitle><addtitle>Schizophr Bull</addtitle><date>2009-01-01</date><risdate>2009</risdate><volume>35</volume><issue>1</issue><spage>163</spage><epage>181</epage><pages>163-181</pages><issn>0586-7614</issn><eissn>1745-1701</eissn><coden>SCZBB3</coden><abstract>The third meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) focused on selecting promising measures for each of the cognitive constructs selected in the first CNTRICS meeting. In the domain of perception, the 2 constructs of interest were gain control and visual integration. CNTRICS received 5 task nominations for gain control and three task nominations for visual integration. The breakout group for perception evaluated the degree to which each of these tasks met prespecified criteria. For gain control, the breakout group for perception believed that 2 of the tasks (prepulse inhibition of startle and mismatch negativity) were already mature and in the process of being incorporated into multisite clinical trials. However, the breakout group recommended that steady-state visual-evoked potentials be combined with contrast sensitivity to magnocellular vs parvocellular biased stimuli and that this combined task and the contrast-contrast effect task be recommended for translation for use in clinical trial contexts in schizophrenia research. For visual integration, the breakout group recommended the Contour Integration and Coherent Motion tasks for translation for use in clinical trials. This manuscript describes the ways in which each of these tasks met the criteria used by the breakout group to evaluate and recommend tasks for further development.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>19023123</pmid><doi>10.1093/schbul/sbn156</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0586-7614
ispartof Schizophrenia bulletin, 2009-01, Vol.35 (1), p.163-181
issn 0586-7614
1745-1701
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2635893
source Oxford Journals Online; PubMed Central
subjects Adult and adolescent clinical studies
Animals
Biological and medical sciences
Clinical Trials as Topic
Evoked Potentials, Visual - physiology
Humans
Magnetic Resonance Imaging
Medical sciences
Perceptual Disorders - diagnosis
Perceptual Disorders - etiology
Psychology. Psychoanalysis. Psychiatry
Psychometrics
Psychopathology. Psychiatry
Psychoses
Reflex, Startle
Schizophrenia
Schizophrenia - complications
Schizophrenia - physiopathology
Theme: Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: Proceedings of the 3rd CNTRICS meeting Guest Editor: Deanna Barch
Visual Perception
title Perception Measurement in Clinical Trials of Schizophrenia: Promising Paradigms From CNTRICS
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T21%3A05%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Perception%20Measurement%20in%20Clinical%20Trials%20of%20Schizophrenia:%20Promising%20Paradigms%20From%20CNTRICS&rft.jtitle=Schizophrenia%20bulletin&rft.au=Green,%20Michael%20F.&rft.date=2009-01-01&rft.volume=35&rft.issue=1&rft.spage=163&rft.epage=181&rft.pages=163-181&rft.issn=0586-7614&rft.eissn=1745-1701&rft.coden=SCZBB3&rft_id=info:doi/10.1093/schbul/sbn156&rft_dat=%3Cproquest_pubme%3E1614441691%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c541t-893ca1e1e684e40ce78e0b6820a73108c087ee34e576178910a8cfb4349fb0203%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=223534809&rft_id=info:pmid/19023123&rft_oup_id=10.1093/schbul/sbn156&rfr_iscdi=true